Photodynamic therapy for chronic central serous chorioretinopathy

Retina

Volumn 23, Issue 6, 2003, Pages 752-763

  Piccolino, Felice Cardillo ^a   Eandi, Chiara M ^a   Ventre, Luca ^a   Rigault De La Longrais, Roberta C ^a   Grignolo, Federico M ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; INDOCYANINE GREEN;

ADULT; AGED; ARTICLE; BIOMICROSCOPY; BLOOD VESSEL PERMEABILITY; CHORIORETINOPATHY; CHOROID VASCULARIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EYE FUNDUS; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; LASER; MALE; MEDICAL PARAMETERS; OPHTHALMOLOGY; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; RECURRENT DISEASE; REMISSION; RETINA DETACHMENT; SAFETY; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; CHOROID DISEASES; CHRONIC DISEASE; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INDOCYANINE GREEN; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RETINAL DETACHMENT; RETINAL DISEASES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0346731198     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200312000-00002     Document Type: Article

References (33)

1. Gass JDM. Pathogenesis of disciform detachment of the neuro-epithelium. II. Idiopathic central serous choroidopathy. Am J Ophthalmol 1967;63:587-615.
2. Klein ML, Van Buskirk EM, Friedman E, Gragoudas E, Chandras S. Experience with nontreatment of central serous chorioretinopathy. Arch Ophthalmol 1974;91:247-250.
3. Yannuzzi LA, Gitter KA, Schatz H. The macula: a comprehensive text and atlas. Baltimore: Williams & Wilkins, 1982; 145-165.
4. Gilbert CM, Owens SL, Smith PD, Fine SL. Long-term follow-up of central serous chorioretinopathy. Br J Ophthalmol 1984;68:815-820.
5. Gass JDM. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. 3rd ed. Vol 1. St. Louis: Mosby, 1987:46-65.
6. Yannuzzi LA, Shakin JL, Fisher YL, Altomonte M. Peripheral detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy. Ophthalmology 1984;91:1553-1572.
7. Jalkh AE, Jabbour N, Avila MP, Trempe CL, Schepens CL. Retinal pigment epithelium decompensation. I. Clinical features and natural course. Ophthalmology 1984;91:1544-1548.
8. Levine R, Brucker A, Robinson F. Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography. Ophthalmology 1989;96:854-859.
9. Loo RH, Scott IU, Flynn HW Jr, et al. Factors associated with reduced visual acuity during long-term follow-up patients with idiopathic central serous chorioretinopathy. Retina 2002;22:19-24.
10. Leaver P, Williams C. Argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol 1979;63:674-677.
11. Robertson DM, Ilstrup D. Direct, indirect and sham laser photocoagulation in the management of central serous chorioretinopathy. Am J Ophthalmol 1983;95:457-466.
12. Ficker L, Vadifis G, While A, Leaver P. Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol 1988;72:829-834.
13. Jalk AE, Jabbour N, Avila M, Trempe CL, Schepens CL. Retinal pigment epithelium decompensation. II. Laser treatment. Ophthalmology 1984;91:1549-1553.
14. Yannuzzi LA. Central serous chorioretinopathy. In: Yannuzzi LA, ed. Laser Photocoagulation of the Macula. Philadelphia: Lippincott, 1989:1-12.
15. Cardillo Piccolino F, Borgia L. Central serous chorioretinopathy and indocyanine green angiography. Retina 1994;14:231-242.
16. Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlok D. Digital indocyanine green angiography of central serous chorioretinopathy. Arch Ophthalmol 1994;112:1057-1062.
17. Cardillo Piccolino F, Borgia L, Zinicola E, Zingirian M. Indocyanine green angiographic findings in central serous chorioretinopathy. Eye 1995;9:324-332.
18. Prunte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 1996;121:26-34.
19. TAP Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials. TAP report 1. Arch Ophthalmol 1999;117:1329-1345.
20. Schmidt-Erfurth U, Hasan T, Gragoudas E, et al. Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology 1994;101:1953-1961.
21. Schmidt-Erfurth U, Miller J, Sickemberg M, et al. Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples. Graefes Arch Clin Exp Ophthalmol 1998;236:365-374.
22. Flower RW, Snyder WA. Expanded hypothesis on the mechanism of photodynamic therapy action on choroidal neovascularization. Retina 1999;19:365-369.
23. Schmidt-Erfurth U, Hasan T. Mechanism of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Surv Ophthalmol 2000;45:195-214.
24. Flower RW, Von Kerczek, Zhu L, et al. Theoretical investigation of the role of choriocapillaris blood flow in treatment of subfoveal choroidal neovascularization associated with age-related macular degeneration. Am J Ophthalmol 2001;132:85-93.
25. Schotzer-Schrehardt U, Viestenz A, Naumann GOH, et al. Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefes Arch Clin Exp Ophthalmol 2002;240:748-757.
26. Schimdt-Erfurth U, Michels S, Barbazetto I, Laqua H. Photodynamic effects on choroidal neovascularization and physiological choroid. Invest Ophthalmol Vis Sci 2002;43:830-841.
27. Kramer M, Miller JW, Michand N, et al. Liposomal benzoporphirin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys. Ophthalmology 1996;103:427-438.
28. Wang MSM, Sander B, Larsen M. Retinal atrophy in idiopathic central serous chorioretinopathy. Am J Ophthalmol 2002;133:787-793.
29. Iida T, Hagimura N, Sato T, Kishi S. Evaluation of central serous chorioretinopathy with optical coherence tomography. Am J Ophthalmol 2000;129:16-20.
30. Husain D, Miller JW, Michand N, et al. Intravenous infusion of liposomal benzoporphirin derivative for photodynamic therapy of experimental choroidal neovascularization. Arch Ophthalmol 1996;114:978-985.
31. Haimovici R, Kramer M, Miller JW, et al. Localization of lipoprotein-delivered benzoporphirin in the rabbit eye. Curr Eye Res 1997;16:83-90.
32. Hayes KC, Lindsey S, Stephan ZF, Brecker D. Retinal pigment epithelium possesses both LDL and scavenger receptor activity. Invest Ophthalmol Vis Sci 1989;30:225-232.
33. Cardillo Piccolino F. Central serous chorioretinopathy: some considerations on the pathogenesis. Ophthalmologica 1981;182:204-210.